Lung Cancer Update
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.
Episodes
Featuring perspectives from Prof Solange Peters and Dr Joshua K Sabari, including the following topics:
- Introduction (0:00)
- Best Option for Your Patient (1:28)
- Biological Considerations (6:26)
- KRAS G12C Inhibitors (11:33)
- Second-Line Treatment (13:02)
- Current Clinical Trials in the First-Line Metastatic Setting (32:18)
- Current Clinical Trials in the Localized Setting (49:52)
- Current Clinical Trials with New Treatment Combinations and A...
Featuring an interview with Prof Ticiana Leal, including the following topics:
- Pathophysiology and clinical signs and symptoms (0:00)
- Screening and/or diagnostic approaches (5:45)
- Potential impact of available therapies for small cell lung cancer (SCLC) on paraneoplastic syndromes (7:36)
- Key clinical trial data for amifampridine and practicalities of its administration (14:05)
- Building awareness among patients, caregivers and the on...
Featuring perspectives from Dr Anne Chiang, Dr Apar Kishor Ganti, Dr Luis Paz-Ares and Dr Misty Dawn Shields, moderated by Dr Shields, including the following topics:
- Introduction (0:00)
- Optimizing First-Line and Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer (SCLC) — Dr Shields (2:17)
- Management of Relapsed/Refractory SCLC — Dr Paz-Ares (33:24)
- Ongoing Investigation and Potential Role of Antibody-Drug C...
Featuring perspectives from Dr John V Heymach and Dr Maurice Pérol, including the following topics:
- Introduction: Relative Impact of Targeted Treatment (00:00)
- HER2 Alterations (8:04)
- KRAS Mutations (24:25)
- MET Overexpression (30:34)
- ALK Fusions (32:34)
- ROS1 Fusions (42:36)
- RET Fusions (52:00)
Featuring perspectives from Dr Joshua K Sabari, including the following topics:
- Jänne PA et al. Final analysis results and patient-reported outcomes from DESTINY-Lung02 — A dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patients with HER2-mutant metastatic NSCLC. J Thorac Oncol 2025;20(12):1814-28. (0:00)
- Heymach JV et al. Circulating tumor DNA (ctDNA) analysis following zongertinib treatment (tx) in p...
Featuring perspectives from Dr Joshua K Sabari, including the following topics:
- Heymach JV et al. Zongertinib in previously treated HER2-mutant non-small cell lung cancer. N Engl J Med 2025;392(23):2321-33. (0:00)
- Popat S et al. Zongertinib as first-line treatment in patients with advanced HER2-mutant NSCLC: Beamion LUNG-1. ESMO 2025;Abstract LBA74. (5:25)
- Le X et al. Sevabertinib in advanced HER2-mutant non-small cell lung cancer...
Featuring perspectives from Dr Sarah B Goldberg, Dr Jonathan Goldman, Dr Joel W Neal, Dr Antonio Passaro and Dr Jacob Sands, moderated by Dr Sands, including the following topics:
- Introduction(00:00)
- Evolving First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) — Prof Passaro (2:27)
- EGFR-Targeted Therapeutic Strategies for Relapsed EGFR-Mutant NSCLC — Dr Neal (36:08)
- Utility of TROP2-Targ...
Featuring an interview with Dr Mark Jeng and Dr Joshua K Sabari, including the following topics:
- Case: A woman in her late 90s with recurrent HER2-mutant metastatic non-small cell lung cancer (NSCLC) receives third-line zongertinib (0:00)
- Case: A woman in her early 60s with multiregimen-recurrent HER2-mutant metastatic NSCLC experiences a response to zongertinib (8:07)
- Case: A man in his mid 80s experiences metastatic recurrence a...
Featuring an interview with Dr Jamie E Chaft, including the following topics:
- Case: A man in his early 70s with a 40 to 50 pack-year history of smoking and cT2bN1 squamous cell carcinoma of the lung with PD-L1 60% treated with induction therapy and surgery(00:00)
- Available clinical data with immunotherapy in the neoadjuvant, perioperative and adjuvant settings (07:45)
- Factors in the selection of adjuvant immunotherapy, including ...
Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics:
- Introduction(0:00)
- Overview of Antibody-Drug Conjugates (ADCs) (2:07)
- Current and Future Role of HER2-Targeted ADCs for Breast Cancer (6:23)
- Currently Available ADCs for Gynecologic Cancer Management (26:37)
- Currently Available ADCs for Lung Cancer Manag...
Featuring perspectives from Dr Lyudmila Bazhenova and Dr Corey J Langer, including the following topics:
- Introduction (0:00)
- Therapeutic Approaches Targeting HER2 and RET — Dr Bazhenova (9:09)
- Therapeutic Approaches Targeting ALK and ROS1 — Dr Langer (31:56)
Featuring perspectives from Dr Jonathan Goldman and Dr Zofia Piotrowska, including the following topics:
- Introduction (0:00)
- Current Management of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) — Dr Goldman (0:38)
- Nonmetastatic EGFR-Mutated NSCLC, Exon 20 Insertion Mutations and Novel Agents — Dr Piotrowska (33:20)
Featuring an interview with Prof Martin Reck, including the following topics:
- Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a strong response to first-line chemoimmunotherapy and maintenance lurbinectedin/atezolizumab(0:00)
- Biology of small cell lung cancer and pharmacodynamics of systemic treatment (3:25)
- Considerations with maintenance therapy for ES-SCLC (9:31)
- Considerations with...
Dr Christine L Hann from the Johns Hopkins University School of Medicine in Baltimore, Maryland, and Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the management of SCLC.
Dr Suresh S Ramalingam and Dr Helena Yu discuss the selection and sequencing of therapy for patients with EGFR mutation-positive non-small cell lung cancer and summarize major advances in the treatment landscape reported over the past year.
CME information and select publications here.
Dr Natalie Vokes from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of lung cancer.
CME information and select publications here.
Dr Hossein Borghaei from Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Dr Anne Chiang from Yale Cancer Center in New Haven, Connecticut, discuss key clinical trial data in the first-line management of ES-SCLC, real-world case studies and current patterns of care among oncologists.
CME information and select publications here.
Dr Luis Paz-Ares from the Spanish National Oncology Research Center in Madrid and Dr Shields from Indiana University School of Medicine in Indianapolis discuss key datasets surrounding first-line and maintenance therapy for patients with extensive-stage small cell lung cancer and their clinical implications.
CME information and select publications here.
Dr Justin F Gainor, Dr Corey J Langer and Dr Misty Dawn Shields summarize the treatment landscape and review relevant clinical datasets for patients with lung cancer.
CME information and select publications here.
Dr John Heymach from The University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for HER2-altered non-small cell lung cancer.
CME information and select publications here.
Popular Podcasts
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by Audiochuck Media Company.
Gregg Rosenthal and a rotating crew of NFL Media hosts including Jourdan Rodrigue, Colleen Wolfe, and Nick Shook provide all the NFL news, previews, recaps and analysis you need to be smarter and funnier than your friends.
The World's Most Dangerous Morning Show, The Breakfast Club, With DJ Envy, Jess Hilarious, And Charlamagne Tha God!
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.